Sleep Questionnaire News Today

Among 26 ResMed-supported abstracts, these were the highlights: New findings show positive airway pressure therapy reduced risks of death and hospitalization for patients with obstructive sleep...

Research presented at ATS 2024 highlights the clinical benefits of PAP therapy in treating sleep-disordered breathing.

AXS-12 statistically significantly reduced cataplexy attacks compared to placebo AXS-12 achieved statistically significant remission of cataplexy compared to placebo AXS-12 statistically...

Axsome Therapeutics announced topline trial results, which show AXS-12 significantly improves key narcolepsy symptoms.

Background: Sleep assessment in the intensive care unit (ICU) is difficult and often unreliable. The most commonly used questionnaire for assessing ICU sleep, the Richards–Campbell Sleep Scale (RCSQ), has not been tested for reliability and construct validity in the Mandarin–Taiwanese speaking population. Objective: The objective of this study was to test the construct validity and criterion validity of the traditional Chinese version of RCSQ (TC-RCSQ) in critically ill patients without phys...

The efficacy and safety of low-sodium oxybate remained stable or improved over 6 months in patients with idiopathic hypersomnia.

Poor quality of life and impaired functioning across many symptom domains were shown in participants in the Real World Idiopathic Hypersomnia Outcomes Study (ARISE).

Nevro (NYSE:NVRO) today announced 24-month data from its Senza painful diabetic neuropathy (PDN) spinal cord stimulation (SCS) trial.

The efficacy and safety of low-sodium oxybate remained stable or improved over 6 months in patients with idiopathic hypersomnia.

Vibrotactile positional therapy devices for positional OSA effectively reduce patients’ AHI and time spent in the supine position.